FDA OKs Lyrica for Spinal Cord Injury

By Cole Petrochko, Associate Staff Writer, MedPage Today

Published: June 21, 2012

The FDA has approved adding use in treatment of spinal cord injury to the indications for the neuropathic pain drug pregabalin (Lyrica).

The new indication makes pregabalin the first FDA-approved treatment for neuropathic pain from spinal cord injury, according to a statement from drug maker Pfizer.

The drug is already approved to treat diabetic nerve pain, pain after shingles, fibromyalgia, and partial-onset seizures in epileptic adults taking one or more seizure drugs. [Read more…]